During the years 1966-1973 474 patients with ovarian carcinoma were treated with melphalan. Of these, 48 patients received at least 300 mg melphalan and survived at least 3 years; four cases of acute leukemia were found among these 48 patients. All cases belonged to a group of 12 cases receiving 800 mg melphalan or more.
No takes yet. Share an insight, caveat, or question.
Nina Einhorn (1978) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: